Burkitts lymphomia is one of the less frequently seen forms of non-Hodgin's lymphomas (non-Hodgekins canser). Burkitts lymphoma is often found in children. It belongs to the B-cell lymphomias which are aggressive in growth although still have a good chance of getting cured using modern cancer treatment methods.
|
|
Burkitt's lymphoma cancer is often seen starting somewhere outside of the lymphatic system. This lymphomia cancer form can be divided into two major classes of cancers; The sporadic Burkitt's limphomas and the endemic Burkitt's lymphomas. This lesser version of of the lymphomia cancers is over-represented in the equatorial band across Africa where this disease is common enough to be classified as endemic. In most other parts of the world, this cancer is rather uncommon and can be classified as a sporadic disease. There is a minor difference in appearance and treatment of symptoms of sporadic and endemic Burkitt's lymphomia cancers.
Not far from every second of all childhood cancer case diagnosed in the equatorial African region is one belonging to the endemic Burkitt's lymphomia types. This type of lymphoma cancer is more likely to be seen developing in children than in adults. It has also been proved that there is a connection between this type of cancer and a prior infection by the Epstein Barr virus. Research has shown that over 95% of patients developing endemic Burkitt has been infected beforehand with the Epstein Barr virus. Endemic Burkitt's lymphoma will often be seen in the jaw bone or in the abdomen or sometimes affeting both of these places.
Hodgekins cancer (Hotchkins disease) is one of the less common cancer forms that got its name after the British dr Hodgkins (Hodgins disease). Non-Hodgekins (non hotchkins) lymphomia cansers are instead the ones more frequently seen. The old division into Hodgins and non-Hotchekins is becoming out of fashion and is now getting replaced by a newer classification of the lymphomas centered on the use of tumor markers for lymphomias.
Get our newsletter here!
Our privacy policy: We will not share your information with anyone else.
Limphoma Research Study
Alemtuzumab (Campathr) for T-LGL Lymphoproliferative Disorders
Notes on Burkitt's Lymphomia
Epidemiologic Notes and Reports Burkitt's Lymphoma
| lymphomia-cancer.com |